This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Axon Therapy (NeuraLace Medical Inc.) for the treatment of chronic neuropathic pain in adults.
Evidence Analysis
It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:
- Does the technology improve health outcomes?
- Are there other benefits associated with the technology?
- What harms might be associated with the technology?
- Have patient selection criteria been established for the technology?
- For which patients might the technology provide a benefit?
- Health Technology Assessments
- Evidence Analysis Research Briefs
- Evolving Evidence Review
- Clinical Research Responses
CardioMEMS Implantable Hemodynamic Monitor (Abbott) for Managing Patients With Heart Failure
Focus of the Report: This Health Technology Assessment focuses on the efficacy and safety of the CardioMEMS implantable hemodynamic monitor (CM-IHM) (Abbott) as an adjunct to the management of patients with heart failure (HF).
Technology Description: The CM-IHM system utilizes an impla…
Ganglion Impar Block or Radiofrequency Thermocoagulation for Treatment of Chronic Coccydynia
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of ganglion impar block (GIB) or radiofrequency thermocoagulation (RFT) of the ganglion impar to treat chronic pain in adults with chronic coccydynia.
Technology Description:
Use of Anti-infliximab Antibody Levels to Monitor Infliximab Treatment in Patients With Crohn Disease
Focus of the Report: This Health Technology Assessment focuses on anti-infliximab (IFX) antibody (ATI) testing in patients who are undergoing IFX treatment for Crohn disease (CD). This testing is a type of therapeutic drug monitoring (TDM) that is performed to help determine whether ongoing treatment is safe and effective and whether changes …
Woven EndoBridge Aneurysm Embolization System (MicroVention Inc.) for Treatment of Intracranial Aneurysms
Focus of the Report: This Health Technology Assessment focuses on the use of the Woven EndoBridge (WEB) aneurysm embolization system, an intrasaccular flow disruption device, for the treatment of intracranial aneurysms (IAs).
Technology Description: T…
Bronchial Thermoplasty for Treatment of Asthma in Adults
Focus of the Report: This Health Technology Assessment focuses on use of bronchial thermoplasty (BT) as an adjunct treatment for severe persistent asthma that remains symptomatic despite medical management with inhaled corticosteroids (ICS) and long-acting beta2 agonists (LABAs).
Technology …
MiVu Mucosal Integrity Testing (Diversatek Inc.) for Diagnosis of Gastroesophageal Reflux Disease in Adults
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of MiVu Mucosal Integrity Testing System (Diversatek Inc.) as an adjunct to clinical endoscopy for the diagnosis of gastroesophageal reflux disease in adults.
Aduhelm (Aducanumab) for Early-Stage/Mild Alzheimer Disease
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of aducanumab (Aduhelm; Biogen Inc.) for the treatment of patients with early-stage Alzheimer disease and mild cognitive symptoms.
Percutaneous Pulmonary Valve Implantation with the Edwards Sapien 3 and Sapien XT Valves (Edwards Lifesciences Corp.) for Right Ventricular Outflow Tract Defects
Focus of the Report: This Health Technology Assessment focuses on percutaneous pulmonary valve implantation (PPVI) with Edwards Sapien 3 or Sapien XT valves for the treatment of right ventricular outflow tract (RVOT) defects.
Technology Description: The goal of PPVI is to improve hemodynamics, cardiopulmonary function, and survival while delaying the n…
Micra Transcatheter Pacing System (Medtronic Inc.) for Single-Chamber Pacemaker Indications
Focus of the Report: This Health Technology Assessment (HTA) focuses on the use of the Micra transcatheter pacing system (TPS) (Medtronic Inc.) as a leadless alternative to traditional transvenous pacemakers (TVPMs) for the management of patients with bradycardia or atrioventricular (AV) block in the presence or absence of atrial fibrillation…